(1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide
C21H28FN3O3 — CID 175566648
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide
(1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide (PubChem CID 175566648) has the molecular formula C21H28FN3O3 and a molecular weight of 389.47 g/mol. Its IUPAC name is (1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide.
Molecular Properties
| Compound Name | (1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 175566648 |
| Molecular Formula | C21H28FN3O3 |
| Molecular Weight | 389.47 g/mol |
| Exact Mass | 389.21 |
| IUPAC Name | (1R)-3-[[(1S)-1-(5-fluoro-3-methyl-1-benzofuran-2-yl)-2-methylpropyl]carbamoylamino]cyclohexane-1-carboxamide |
| SMILES | Cc1c([C@@H](NC(=O)NC2CCC[C@@H](C(N)=O)C2)C(C)C)oc2ccc(F)cc12 |
| InChI | InChI=1S/C21H28FN3O3/c1-11(2)18(19-12(3)16-10-14(22)7-8-17(16)28-19)25-21(27)24-15-6-4-5-13(9-15)20(23)26/h7-8,10-11,13,15,18H,4-6,9H2,1-3H3,(H2,23,26)(H2,24,25,27)/t13-,15?,18+/m1/s1 |
| InChIKey | DBDPTQRVZGLWRA-CLIJRUEWSA-N |
| XLogP | 3.92 |
| TPSA | 97.36 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 389.47 |
| LogP ≤ 5 | 3.92 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175566648 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.